Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Mangoceuticals, Inc. - Common Stock (NQ:MGRX)

0.7127 -0.0573 (-7.44%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 478,424
Open 0.7200
Bid (Size) 0.7110 (1,100)
Ask (Size) 0.7240 (500)
Prev. Close 0.7700
Today's Range 0.7032 - 0.7700
52wk Range 0.5241 - 6.150
Shares Outstanding 13,906,570
Dividend Yield N/A

Performance

YTD
-71.4%
-71.4%
1 Month
-35.8%
-35.8%
3 Month
-66.2%
-66.2%
6 Month
-53.1%
-53.1%
1 Year
-72.6%
-72.6%

More News

Read More

Frequently Asked Questions

Is Mangoceuticals, Inc. - Common Stock publicly traded?
Yes, Mangoceuticals, Inc. - Common Stock is publicly traded.
What exchange does Mangoceuticals, Inc. - Common Stock trade on?
Mangoceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mangoceuticals, Inc. - Common Stock?
The ticker symbol for Mangoceuticals, Inc. - Common Stock is MGRX on the Nasdaq Stock Market
What is the current price of Mangoceuticals, Inc. - Common Stock?
The current price of Mangoceuticals, Inc. - Common Stock is 0.7127
When was Mangoceuticals, Inc. - Common Stock last traded?
The last trade of Mangoceuticals, Inc. - Common Stock was at 12/26/25 04:00 PM ET
What is the market capitalization of Mangoceuticals, Inc. - Common Stock?
The market capitalization of Mangoceuticals, Inc. - Common Stock is 9.91M
How many shares of Mangoceuticals, Inc. - Common Stock are outstanding?
Mangoceuticals, Inc. - Common Stock has 10M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.